ASRT logo

ASRT
Assertio Holdings Inc

15,736
Mkt Cap
$86.17M
Volume
76,247.00
52W High
$15.15
52W Low
$7.71
PE Ratio
-2.71
ASRT Fundamentals
Price
$13.37
Prev Close
$13.72
Open
$13.75
50D MA
$11.74
Beta
1.26
Avg. Volume
38,453.93
EPS (Annual)
-$4.74
P/B
0.91
Rev/Employee
$2.24M
$34.92
Loading...
Loading...
News
all
press releases
Assertio Q4 Earnings Call Highlights
Assertio (NASDAQ:ASRT) executives used the company's fourth-quarter and full-year 2025 earnings call to outline a sharper strategic focus on growing its oncology franchise around Rolvedon, while...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
Assertio (ASRT) delivered earnings and revenue surprises of +39.02% and +185.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
Assertio (NASDAQ:ASRT) Issues Quarterly Earnings Results, Beats Expectations By $1.99 EPS
Assertio (NASDAQ:ASRT - Get Free Report) released its quarterly earnings results on Monday. The company reported ($1.06) earnings per share (EPS) for the quarter, beating the consensus estimate of...
MarketBeat·4d ago
News Placeholder
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients...
Business Wire·4d ago
News Placeholder
Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4
Plus (PSTV) delivered earnings and revenue surprises of +100.00% and +2.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
Immunovant Stock Surges 17% in 3 Months: What's Driving It?
IMVT gains 17% in three months as IMVT-1402 advances across autoimmune trials, with multiple data readouts due in 2026-2027, and $994.5M cash backing development.
Zacks·15d ago
News Placeholder
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know
Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships for international growth fuel optimism.
Zacks·16d ago
News Placeholder
Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?
Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.
Zacks·17d ago
News Placeholder
Assertio (ASRT) Projected to Post Quarterly Earnings on Wednesday
Assertio (NASDAQ:ASRT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 11. (View Earnings Report at...
MarketBeat·17d ago
News Placeholder
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Assertio Holdings, Inc. (Assertio) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, 2026, after the market close. Following...
Business Wire·17d ago
<
1
2
...
>

Latest ASRT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.